The latest closing stock price for VistaGen Therapeutics as of September 19, 2024 is 3.00.
An investor who bought $1,000 worth of VistaGen Therapeutics stock at the IPO in 2016 would have $-976 today, roughly -1 times their original investment - a -37.15% compound annual growth rate over 8 years.
The all-time high VistaGen Therapeutics stock closing price was 132.30 on October 04, 2016.
The VistaGen Therapeutics 52-week high stock price is 5.86, which is 95.3% above the current share price.
The VistaGen Therapeutics 52-week low stock price is 2.45, which is 18.3% below the current share price.
The average VistaGen Therapeutics stock price for the last 52 weeks is 4.13.
An investor who bought $1,000 worth of VistaGen Therapeutics stock at the IPO in 2016 would have $-976 today, roughly -1 times their original investment - a -37.15% compound annual growth rate over 8 years.
The all-time high VistaGen Therapeutics stock closing price was 132.30 on October 04, 2016.
The VistaGen Therapeutics 52-week high stock price is 5.86, which is 95.3% above the current share price.
The VistaGen Therapeutics 52-week low stock price is 2.45, which is 18.3% below the current share price.
The average VistaGen Therapeutics stock price for the last 52 weeks is 4.13.